Transplant Research and Risk Management

译名:移植研究与风险管理

ESCIJCR Q4

<1

2025

影响因子区间

平台估算

投稿周期

0%

2025

中国作者发文占比

40000000 IRR;600 USD

费用说明

收费

期刊简介:This title has ceased (2024). Transplant Research and Risk Management is an international, peer-reviewed, open access journal focusing on all aspects of transplantation and risk management to achieve optimal outcomes in the recipient improving survival and quality of life. Specific topics covered in the journal include: Screening and tissue matching, Cell biology, immunology and therapy, Experimental and clinical transplantation, Rejection management, optimal use of immunosuppressants and supportive drugs, Development of novel agents, techniques and procedures, Ethics and policy, Patient adherence and quality of life, Health economic evaluations and resource management. The journal welcomes submitted papers covering original research, basic science, clinical studies, reviews and evaluations, guidelines, expert opinion and commentary, case reports and extended reports. Transplant Research and Risk Management will no longer consider meta-analyses for publication.

【译文】该头衔已终止(2024 年)。移植研究和风险管理是一本国际性的、同行评审的开放获取期刊,重点关注移植和风险管理的各个方面,以实现受者的最佳结果,提高生存率和生活质量。该杂志涵盖的具体主题包括:筛选和组织匹配、细胞生物学、免疫学和治疗、实验和临床移植、排斥管理、免疫抑制剂和支持药物的最佳使用、新型药物、技术和程序的开发、伦理和政策、患者依从性和生活质量、健康经济评估和资源管理。该杂志欢迎提交涵盖原始研究、基础科学、临床研究、评论和评估、指南、专家意见和评论、病例报告和扩展报告的论文。移植研究和风险管理将不再考虑发表荟萃分析。

出版社
Dove Medical Press
语言
English
学科
医学
ISSN
1179-1616
eISSN
1179-1616
出版频率
年刊
创刊年份
1981
投稿网址
http://www.dovepress.com/transplant-research-and-risk-management-journal
最近更新
2026-04-02 18:16:40

指标当前值近三年趋势
JCR分区Q4
暂无
影响因子区间<1
暂无